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Genetic deletion of the adenosine A1 receptor (A1AR)
increased renal injury following ischemia–reperfusion injury
suggesting that receptor activation is protective in vivo. Here
we tested this hypothesis by expressing the human-A1AR in
A1AR knockout mice. Renal ischemia–reperfusion was
induced in knockout mice 2 days after intrarenal injection of
saline or a lentivirus encoding enhanced green fluorescent
protein (EGFP) or EGFP-human-A1AR. We found that the
latter procedure induced a robust expression of the reporter
protein in the kidneys of knockout mice. Mice with kidney-
specific human-A1AR reconstitution had significantly lower
plasma creatinine, tubular necrosis, apoptosis, and tubular
inflammation as evidenced by decreased leukocyte
infiltration, pro-inflammatory cytokine, and intercellular
adhesion molecule-1 expression in the kidney following
injury compared to mice injected with saline or the control
lentivirus. Additionally, there were marked disruptions of the
proximal tubule epithelial filamentous (F)-actin cytoskeleton
in both sets of control mice upon renal injury, whereas the
reconstituted mice had better preservation of the renal
tubule actin cytoskeleton, which co-localized with the
human-A1ARs. Consistent with reduced renal injury, there
was a significant increase in heat shock protein-27
expression, also co-localizing with the preserved F-actin
cytoskeleton. Our findings suggest that selective expression
of cytoprotective A1ARs in the kidney can attenuate renal
injury.
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Acute renal failure (ARF) is a major clinical problem without
effective therapy and contributes greatly to patient morbidity
and mortality.1–3 Development of ARF implies a poor
prognosis and is frequently complicated by multiorgan
failure and sepsis. Despite considerable research, mortality
and morbidity from ARF have changed little over the past 40
years.1 Ischemia–reperfusion (IR) injury participates in the
pathophysiology of ARF and occurs frequently due to the
obligatory interruption of blood flow and undesirable
hemodynamic changes during the perioperative period.4–6
These events lead to renal tubular necrosis, particularly in the
proximal tubule cells located in the outer medullary region
along the corticomedullary junction, which are the most
susceptible to injury and cell death.7,8
Our laboratory showed previously that exogenous and
endogenous A1 adenosine receptor (AR) activation protected
against renal IR injury in mice9,10 as well as in rats.11,12
Specifically, animals treated with a selective A1AR agonist
before renal ischemia showed reduced renal corticomedullary
necrosis, apoptosis, and inflammation.9 Moreover, mice
treated with an A1AR antagonist or mice globally lacking
A1ARs (A1AR knockout (KO) mice) showed increased renal
injury after IR injury. Therefore, endogenous as well as
exogenous activation of A1ARs appear to serve a protective
role against renal IR injury. However, in these previous
studies, we used mice with global genetic deletion of A1ARs
as well as mice subjected to systemic pharmacological
antagonism of A1ARs. The global nature of A1AR antagon-
ism/deletion somewhat limits the conclusions of these studies
that renal A1ARs are directly involved in the renal protective
effects of adenosine.
We recently showed that in cultured renal proximal tubule
cells, overexpression of A1ARs led to an increased resistance
against necrosis and apoptosis without treatment with an
exogenous A1AR agonist through upregulation of heat shock
protein 27 (HSP27).13 Therefore, in this study, we questioned
whether relatively selective renal expression of A1ARs in mice
lacking A1ARs through viral gene delivery would increase the
resistance against renal IR injury. We tested the hypothesis
that expression of A1ARs in the kidneys of A1AR KO mice
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would improve renal function and reduce necrosis, inflam-
mation, and apoptosis after IR injury.
We used intrarenal gene delivery with a lentiviral vector
that expresses either enhanced green fluorescent protein
(EGFP) or EGFP-huA1AR. We subsequently probed for the
expression of transgene in the injected kidney and elsewhere.
We also subjected mice to renal IR injury after their kidneys
were injected with lentivirus encoding EGFP or EGFP-
huA1AR. Finally, we probed the mechanisms of renal
protection with EGFP-huA1AR overexpression by examining
whether huA1AR overexpression in A1AR KO mice leads to
(1) HSP27 upregulation resulting in enhanced colocalization
with F-actin cytoskeleton and/or (2) enhanced A1AR-
mediated vasoconstriction with subsequent induction hypox-
ia-inducible factors (HIFs) and HIF-dependent protective
genes leading to renal protection.
We show that mice renally injected with EGFP-huA1AR
lentivirus showed (1) significant renal protection against IR
injury with reduced necrosis, inflammation, and apoptosis
when compared with mice injected with EGFP lentivirus and
(2) upregulation of HSP27 and increased co-localization with
F-actin cytoskeleton.
RESULTS
In vivo renal expression of EGFP or EGFP-huA1AR after
intrarenal lentiviral gene delivery in A1AR KO mice
None of the mice died or showed signs of ARF after lentiviral
injection to their kidneys. Figure 1a ( 40) and Figure 1b
( 200) show that intrarenal delivery of lentivirus encoding
EGFP (middle panels) or EGFP-huA1AR (bottom panels)
resulted in a robust expression of EGFP in the renal cortex
and corticomedullary junction (primarily S3 segments of
proximal tubule as the major tubular segment represented)
48 h after injection. Low-magnification images ( 40) clearly
show that EGFP expression was localized mostly to the cortex
and the corticomedullary junction.
Saline-injected kidneys showed faint green auto-fluores-
cence (top panels). EGFP expression in the medulla of the
injected kidneys (concentration of collecting ducts and thin
limbs of Henle, data not shown) were much weaker
compared with the cortical areas and corticomedullary
junction. Moreover, EGFP expression was undetectable
(similar to baseline green autofluorescence) in the contral-
ateral kidney, heart, or lungs of A1AR KO mice injected with
either lentiviral construct (data not shown). Figure 1c shows
the expression of human A1AR mRNA (detected with
RTPCR, 40 cycle amplification) in the renal cortices of
A1AR KO mice renally injected with the EGFP-huA1AR
lentivirus but not in the renal cortices of mice injected with
the EGFP lentivirus. Contralateral kidneys of EGFP-huA1AR
lentivirus-injected mice showed slight and significantly weaker
expression of A1ARs detected with 40 cycles of RT-PCR.
We also confirmed the expression of huA1ARs in EGFP-
huA1AR renally injected mice using immunohistochemistry.
Figure 2 shows that the A1AR KO mice injected with EGFP-
huA1AR lentivirus show a robust expression of huA1ARs
(red), whereas the A1AR KO mice injected with EGFP
lentivirus failed to show any expression. Furthermore, with
0.25 mm Z-sections, we were able to show that huA1ARs (red)
and EGFP (green) colocalize together (yellow, Figure 2f).
A1AR KO mice renally expressing EGFP-huA1ARs are
protected against renal IR injury
After 30 min of renal ischemia and 24 h of reperfusion,
plasma creatinine (mg/100 ml) increased significantly in both
A1AR KO mice renally injected with saline (Cr¼ 2.28±0.08,
N¼ 8, Po0.01) or lentivirus encoding EGFP
(Cr¼ 2.33±0.23, N¼ 9, Po0.01) compared with sham-
operated mice injected with saline (Cr¼ 0.44±0.08, N¼ 5)
or EGFP (Cr¼ 0.63±0.07, N¼ 5). In contrast, mice renally
injected with lentivirus encoding EGFP-huA1AR 48 h showed
previously significant renal protection after IR injury
(Cr¼ 0.83±0.06, N¼ 9, Po0.01 vs saline-injected or
EGFP-lentivirus-injected A1AR KO mice subjected to renal
IR, Figure 3).
A1AR KO mice renally expressing EGFP-huA1ARs show less
renal tubular necrosis after renal IR
Thirty minutes of renal ischemia followed by 24 h of
reperfusion resulted in significant renal injury in both
A1AR KO mice renally injected with saline or lentivirus
encoding EGFP (Figure 4) as evidenced by severe tubular
necrosis, corticomedullary congestion and hemorrhage, and
development of proteinaceous casts in all mouse kidney
sections. However, the A1AR KO mice renally injected with
lentivirus encoding EGFP-huA1AR had significantly less renal
tubular damage and necrosis after renal IR. The Jablonski
scale renal injury score histology grading is used to grade
renal tubular necrosis after murine renal IR injury.14 Thirty
minutes of renal ischemia and 24 h of reperfusion resulted in
severe acute tubular necrosis in both A1AR KO mice renally
injected with saline (renal injury score¼ 3.3±0.3, N¼ 5) or
lentivirus encoding EGFP (renal injury score¼ 3.1±0.2,
N¼ 8), whereas mice renally injected with a lentivirus
encoding EGFP-huA1AR had significantly lower renal injury
score (1.7±0.2, N¼ 5, Po0.001 vs mice injected with saline
or EGFP).
A1AR KO mice renally expressing EGFP-huA1ARs show
reduced proinflammatory gene expression in the kidney
after renal IR
We found significantly increased expression of keratinocyte-
derived cytokine (KC), intercellular adhesion molecule-1
(ICAM-1), monocyte chemoattractive protein-1 (MCP-1),
macrophage inflammatory protein-2 (MIP-2), and tumor
necrosis factor-alpha (TNF-a) in A1AR KO mice subjected to
renal IR after renally injected with saline or lentivirus
encoding EGFP (N¼ 5). The A1AR KO mice renally injected
with lentivirus encoding EGFP-huA1AR had significantly
reduced expression of all pro-inflammatory mRNAs expres-
sion except for MIP-2 and KC 24 h after renal IR (N¼ 5,
Figure 5).
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A1AR KO mice renally expressing EGFP-huA1ARs show
reduced renal neutrophil infiltration and ICAM-1 expression
after renal IR
Immunohistochemical assays showed an increase in neutro-
phil infiltration and ICAM-1 expression (Figure 6) in A1AR
KO mice renally injected with saline or with lentivirus
encoding EGFP at 24 h after renal IR injury. The A1AR KO
mice renally injected with lentivirus encoding EGFP-huA1AR
had significantly reduced neutrophil infiltration and ICAM-1
expression after renal IR. Manual counting of polymorpho-
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Figure 1 | Selective cortico-medullary expression of huA1AR and EGFP via lentiviral gene delivery. Representative kidney fluorescent
photomicrographs of five experiments from A1AR KO mice (original magnification of (a)  40 and (b)  200) demonstrating predominant
localization of EGFP expression in the cortex and corticomedullary junction with relative sparing of the medullary areas. A1AR KO mouse kidneys
were renally injected with saline, EGFP encoding lentivirus, or EGFP-huA1AR encoding lentivirus, and 48 h later, their kidneys were embedded in
oxytetracycline compound. (Top) A1AR KO mouse kidney injected with saline only. (Middle) A1AR KO mouse kidney injected with EGFP encoding
lentivirus. (Bottom) A1AR KO mouse kidney injected with EGFP-huA1AR encoding lentivirus. (c) Representative gel images of RT–PCR results from
six experiments for GAPDH and A1AR from A1AR KO mice renal cortices. A1AR KO mouse kidneys were injected with EGFP encoding lentivirus or
EGFP-huA1AR encoding lentivirus 48 h before RT-PCR. Representative results from injected and contralateral kidneys are shown.
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nuclear cells in hematoxylin-and-eosin (H&E) slides also
showed increased neutrophil infiltration in both saline-
(48±15 neutrophils/ 400 field, N¼ 8) or EGFP-injected
A1AR KO mice (35±10 neutrophils/ 400 field, N¼ 8)
compared with the A1AR KO mice injected with EGFP-
huA1AR lentivirus (5±3 neutrophils/ 400 field, N¼ 5,
Po0.001 vs mice injected with saline or EGFP) 24 h after
renal IR.
A1AR KO mice renally expressing EGFP-huA1ARs show
reduced renal apoptosis after IR
We failed to detect significant terminal deoxynucleotidyl
transferase biotin-dUTP nick end-labeling (TUNEL)-positive
cells in kidney sections from sham-operated mice
renally injected with saline, lentivirus encoding EGFP, or
EGFP-huA1AR (Figure 7). The A1AR KO mice renally
injected with saline or with EGFP lentivirus 48 h before
and subjected to 30 min of renal ischemia and 24 h of
reperfusion showed many TUNEL-positive cells in the
corticomedullary junction (Figure 7). The A1AR KO
mice renally injected with lentivirus encoding EGFP-huA1AR
had reduced TUNEL-positive renal tubule cells. The
degree of renal tubular apoptosis was also quantified by
counting the number of apoptotic bodies in proximal tubules
in the corticomedullary area of the kidney (expressed as
apoptotic bodies per tubule) on the H&E-stained sections
( 400). Renal IR injury equivalently increased the number
of apoptotic bodies within the proximal tubules in both
saline- (0.07±0.03 apoptotic bodies per tubule, N¼ 7) or
lentivirus encoding EGFP-injected A1AR KO mice
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Figure 2 | Co-localization of huA1ARs and EGFP in the kidney after lentiviral gene delivery. Representation of four
immunohistochemistry fluorescence photomicrographs for (a, b) huA1ARs (red) and (c, d) EGFP expression (green) in A1AR KO mice renally
injected with either (a, c, e) EGFP or (b, d, f) EGFP-huA1AR lentivirus 48 h earlier. (e, f) With 0.25mm thickness Z-sections, we were able to
show that huA1ARs (red) and EGFP (green) colocalize together (yellow).
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(0.08±0.04 apoptotic bodies per tubule, N¼ 8). The number
of apoptotic bodies counted was reduced for A1AR KO
mice injected with EGFP-huA1AR lentivirus (0.03±0.01
apoptotic bodies per tubule, N¼ 5, Po0.05 vs mice injected
with saline or EGFP). Finally, Figure 8 shows that mice
subjected to renal IR after EGFP lentivirus renal injection
showed significant caspase 3 and poly-ADP ribose polymer-
ase (PARP) fragmentation, whereas mice injected with
lentivirus encoding EGFP-huA1AR showed reduced
caspase 3 and PARP fragmentation. Saline-injected mice
subjected to IR showed similar degree of caspase 3 and PARP
fragmentation as mice injected with EGFP lentivirus (data
not shown).
A1AR KO mice expressing EGFP-huA1ARs show reduced
disruption of renal proximal tubule filamentous (F)-actin
architecture
As expected, renal IR injury resulted in severe disruption of
renal proximal tubule F-actin compared with the sham-
operated mice. In Figure 9, post-ischemic disruption of the
F-actin cytoskeleton in renal proximal tubular epithelial cells
is shown. The A1AR KO mice subjected to sham surgery
showed intense staining in the tubular epithelial cell basal
plasma membrane. In contrast, kidneys from mice renally
injected with saline or EGFP encoding lentivirus and
subjected to renal IR showed significant loss of F-actin
staining in the tubular epithelial cells. The A1AR KO mice
injected with EGFP-huA1AR encoding lentivirus show
reduced disruption or increased polymerized form of renal
proximal tubule filamentous-actin architecture after IR.
Fluorescent microscopy also showed increased coexpression
of EGFP-huA1ARs (green) and F-actin (red) in proximal
tubules in A1AR KO mice injected with EGFP-huA1AR
lentivirus but not in mice injected with EGFP lentivirus
(Figure 9).
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Figure 3 | Plasma creatinine (Cr in mg/100 ml) from A1AR KO
mice injected with saline, EGFP encoding lentivirus, or EGFP-
huA1AR encoding lentivirus and subjected to sham operation
(Sham) or ischemia–reperfusion (IR) injury. Mice were
subjected to sham surgery (N¼ 5 each) or renal IR 48 h after renal
injection with saline (N¼ 8) or EGFP (N¼ 9) or EGFP-huA1AR
(N¼ 9) encoding lentivirus, and plasma creatinine was measured
24 h after reperfusion. *Po0.05 vs appropriate sham-operated
A1AR KO mice.
#Po0.05 vs A1AR KO saline-injected mice
subjected to renal IR. Data presented as mean±s.e.m.
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Figure 4 | Representative photomicrographs of six experiments (hematoxylin-and-eosin staining, original magnification  200)
with A1AR KO mice renally injected with saline, EGFP lentivirus, or EGFP-huA1AR lentivirus and subjected to sham operation or to
renal IR. Pictures of the outer medulla of the kidneys of sham-operated mice and mice subjected to renal ischemia–reperfusion (IR) injury
24 h earlier are shown.
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Figure 5 | Lentivirus-mediated expression of huA1ARs reduces pro-inflammatory gene expression after renal IR injury.
(a) Representative gel images of semiquantitative RT-PCR of the proinflammatory markers ICAM-1, KC, MCP-1, MIP-2, and TNF-a from
renal cortices of A1AR KO mouse kidneys renally injected with saline, EGFP lentivirus, or EGFP-huA1AR lentivirus and subjected to sham
operation or to renal ischemia and 24 h of reperfusion. (b) Densitometric quantification of relative band intensities normalized to GAPDH
from RT-PCR reactions for each indicated mRNA (N¼ 5). *Po0.05 vs appropriate sham-operated A1AR KO mice. #Po0.05 vs A1AR KO saline
renally injected mice subjected to renal IR. Error bars represent 1 s.e.m.
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A1AR KO mice renally expressing EGFP-huA1ARs show
increased HSP27 mRNA and protein expression and
enhanced colocalization of F-actin with HSP27
Figure 10 shows that injection of EGFP-huA1AR lentivirus in
A1AR KO mice resulted in increased HSP27 mRNA
expression compared with EGFP lentivirus-injected mice.
We also observed increased HSP27 protein expression (red
fluorescence) detected with immunocytochemistry in EGFP-
huA1AR lentivirus-injected A1AR KO mice (Figure 11).
Furthermore, we saw increased colocalization of HSP27
(red fluorescence) and F-actin (green fluorescence) in EGFP-
huA1AR lentivirus-injected A1AR KO mice.
A1AR KO mice renally expressing EGFP-huA1ARs do not
upregulate HIF expression
We performed HIF-1a and HIF-2a immunoblotting 48 h after
intrarenal injection of lentivirus encoding EGFP or EGFP-
huA1AR. We saw no induction of HIF with similar expression
of HIF-1a and HIF-2a in both groups (data not shown).
DISCUSSION
In this study, we selectively expressed A1ARs in the
kidneys of mice genetically lacking A1ARs (A1AR KO) by
injecting the kidney with lentivirus packaged with the
EGFP-huA1AR transgene. We showed that intraparenchymal
injection of lentivirus preferentially expresses the transgene
in the renal cortex and corticomedullary junction and
that A1AR expression is concentrated within the injected
kidney. Moreover, the expression of human A1ARs
improved renal function in A1AR KO mice after renal IR
and this renal protection was associated with reduced
renal tubular necrosis, inflammation, and apoptosis.
Finally, expression of human A1ARs in A1AR KO
mice increased HSP27 expression and colocalization with
the F-actin cytoskeleton. Therefore, lentiviral delivery of
A1ARs may potentially be used to protect against renal IR
injury.
We showed previously that overexpression of A1ARs led to
increased endogenous resistance against necrosis and apop-
tosis in cultured renal tubules in vitro.13 We concluded from
this previous study that upregulation of renal tubule A1ARs is
sufficient to produce increased cytoprotective signaling
through activation of ARs with endogenously produced
adenosine. We also showed in our previous studies that
exogenous A1AR activation produced renal protection in vivo
as well as in vitro.9,10,13,15 Moreover, the A1AR wild-type mice
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Figure 6 | Reduced neutrophil infiltration with lentiviral gene huA1AR delivery after renal IR injury. Representative photomicrographs
( 200) of four experiments of immunohistochemistry for neutrophil infiltration (top and middle panel) or ICAM-1 expression (bottom
panel) in the outer medulla of the kidneys of A1AR KO mice renally injected with saline, EGFP encoding lentivirus, or EGFP-huA1AR encoding
lentivirus and subjected to sham operation (top panel) or to renal ischemia and 24 h of reperfusion (middle and bottom panels).
Kidney International (2009) 75, 809–823 815
M Kim et al.: A1ARs and renal ischemia–reperfusion injury o r i g i n a l a r t i c l e
treated with an A1AR antagonist (DPCPX) or mice globally
lacking A1ARs showed exacerbated renal injury characterized
by increased necrosis, inflammation, and apoptosis.9,10
However, in these previous in vivo studies, the A1ARs were
modulated globally and not just in the kidneys. Therefore, in
this study, we questioned whether a selective renal expression
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Figure 7 | Representative fluorescence photomicrographs of kidney sections illustrating apoptotic nuclei (terminal
deoxynucleotidyl transferase biotin-dUTP nick end-labeling (TUNEL) fluorescence staining,  100) in the outer medulla of the
kidneys. A1AR KO mouse kidneys were renally injected with saline, EGFP encoding lentivirus, or EGFP-huA1AR encoding lentivirus and
subjected to sham operation or to renal ischemia and 24 h of reperfusion.
A1KO mice
injected with
EGFP
Sham Sham
Pro-caspase 3
Uncleaved
PARP
A1KO mice
injected with
EGFP-A1AR
Sham IR
0.0
0.2
0.4
0.6
0.8
1.0
EGFP encoding lentivirus
renally injected A1AR KO mice
EGFP-A1AR encoding lentivirus
renally injected A1AR KO mice
*
#
R
el
at
iv
e 
ex
pr
es
sio
n
o
f u
nc
le
av
ed
 P
AR
P
Sham IR
0.0
0.2
0.4
0.6
0.8
1.0
*
#
R
el
at
iv
e 
ex
pr
es
sio
n
o
f u
nc
le
av
ed
 c
as
pa
se
 3
IR IR
Figure 8 | Reduction in renal apoptosis with lentiviral gene huA1AR delivery after renal IR injury. (a) Representative immunoblotting
images from four separate experiments for uncleaved poly-ADP ribose polymerase (PARP) and caspase 3 in A1AR KO mouse renal cortices.
A1AR KO mouse kidneys injected with saline, lentivirus encoding EGFP, or lentivirus encoding EGFP-huA1AR were subjected to sham
operation or 30 min renal ischemia and 24 h reperfusion. (b) Densitometric quantifications of unfragmented PARP (top, N¼ 4) and caspase 3
(bottom, N¼ 4) from A1AR KO mouse renal cortices injected with lentivirus encoding EGFP or lentivirus encoding EGFP-huA1AR 24 h after
sham operation or IR. *Po0.05 vs sham-operated mice. #Po0.05 vs A1AR KO EGFP encoding lentivirus injected mice subjected to renal IR.
816 Kidney International (2009) 75, 809–823
o r i g i n a l a r t i c l e M Kim et al.: A1ARs and renal ischemia–reperfusion injury
of A1ARs in A1AR KO mice would lead to improved renal
function after IR in vivo.
We achieved selective transduction of both EGFP and
EGFP-huA1AR in the renal cortex and corticomedullary
junction of kidneys injected with lentivirus, as indicated by a
lack of green fluorescence in the contralateral kidney, heart,
or lungs of A1AR KO mice injected with lentiviruses encoding
these constructs. We further confirmed the selective protein
expression resulting from lentivirus injections by showing
that A1AR KO mice injected with EGFP-huA1AR lentivirus
express huA1AR protein (immunocytochemistry, Figure 2),
whereas mice injected with EGFP lentivirus do not. Although
some human A1AR mRNA was detected in contralateral
kidneys of renally injected A1AR KO mice, the level of mRNA
expression was significantly lower relative to the A1AR
expression levels in the injected kidney. Therefore, our
method of lentiviral gene delivery allowed us to directly test
the hypothesis that restoration of A1AR expression in the
kidney of A1AR KO mice improves renal function after IR
injury.
The expression of A1ARs fused with EGFP was observed
primarily in the cortex and at the corticomedullary junction.
At this site, there are primarily S3 segments of proximal
tubule as the major tubular segment represented. Expression
was nearly undetectable in the inner medulla where there is a
concentration of collecting ducts and thin limbs of Henle.
The major site of injury in our model of warm renal IR
predominantly affects the ‘outer stripe’ of outer medulla
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Figure 9 | Reduction in F-actin disruption with lentiviral gene huA1AR delivery after renal IR injury. Representative fluorescent
photomicrographs of (a, b) phalloidin labeling (red) to visualize (c, d) F-actin and EGFP expression (green) in renal proximal tubules from
A1AR KO mouse kidneys. A1AR KO mouse kidneys were renally injected with either (a, c, e) EGFP (identical fields shown) or (b, d, f) EGFP-
huA1AR lentivirus (identical fields shown) 48 h earlier and subjected to 30 min renal ischemia and 24 h reperfusion.
#Indicates proximal
tubules with disrupted F-actin staining and *indicates intact F-actin cytoskeleton. We show that proximal tubules expressing EGFP (green)
show better preserved F-actin (red) and (e, f) coexpress together (yellow). Representative images of six independent experiments.
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corresponding to the S3 segments of proximal tubule, which
is located precisely at the corticomedullary junction.7,8
Selective A1AR expression in the kidneys of mice lacking
A1ARs protected against renal IR injury as evidenced by a
reduction in plasma creatinine levels in these mice. This
reduction in serum creatinine corresponded with a reduction
in proinflammatory cytokine expression (ICAM-1, TNF-a,
and MCP-1), neutrophil infiltration, and ICAM-1 expression
in the kidneys of A1AR KO mice injected with EGFP-
huA1AR, all of which have been shown previously to be
important mediators in renal IR injury.16,17 Moreover, the
A1AR KO mice renally injected with the EGFP-huA1AR
encoding lentivirus had significantly less renal tubular
necrosis of the ‘outer stripe’ of outer medulla and reduced
renal tubular apoptosis (TUNEL staining, PARP, and caspase
3 fragmentation). Finally, we showed a significant loss of
renal tubular F-actin cytoskeleton structure after renal IR in
EGFP- or saline-injected mice, whereas the lentivirus-
mediated expression of huA1ARs preserved the F-actin
cytoskeleton after renal IR in A1AR KO mice. Areas with
reduced necrosis and preserved F-actin after renal IR are the
areas with heavy EGFP expression after EGFP-huA1AR
lentivirus injection. Therefore, we provide multiple layers of
evidence that renal expression of A1ARs provide renal
protection in mice genetically lacking A1ARs. Moreover, this
as well as our previous studies collectively show that both
endogenous and exogenous A1AR activation can protect the
kidney. Furthermore, expression of human A1ARs in the
mouse kidneys is able to provide renal protection in A1AR
KO mice by using endogenous mouse adenosine.
Surprisingly, KC as well as MIP-2 mRNA levels was not
reduced after EGFP-huA1AR injection, despite significant
improvements in renal function and a reduction in several
key inflammatory markers. KC and MIP-2 are well known
chemotactic cytokines and function to attract the neutrophils
to the site of injury.18,19 Despite the lack of changes in KC
and MIP-2 expression, we saw a drastic reduction in
neutrophil and ICAM-1 protein expression in mice injected
with EGFP-huA1AR lentivirus. These findings suggest that
redundancy in chemokine function exists in modulating
renal IR injury, and reduction of other proinflammatory
cytokine expression (for example, TNF-a and MCP-1) is
sufficient to modulate the expression of ICAM-1 and
neutrophil infiltration after renal IR.
We showed in this study that intrarenal injection of EGFP-
huA1AR lentivirus increased HSP27 mRNA as well as protein.
We previously showed that A1AR activation phosphorylates
cytoprotective kinases extracellular signal-regulated kinase-1/2,
mitogen-activated protein kinase, and acutely transforming
retrovirus AKT8 in rodent T cell lymphoma as well as
HSP2713,20 in renal proximal tubules. Moreover, renal tubular
A1AR activation led to the synthesis of new HSP27.
Therefore, expression of EGFP-huA1AR in A1AR KO mice
most likely produces renal protection through activation of
extracellular signal-regulated kinase-1/2 and acutely trans-
forming retrovirus AKT8 in rodent T cell lymphoma and
induction/phosphorylation of HSP27 in renal proximal
tubules.
Heat shock protein 27 is a member of family of chaperone
proteins that are upregulated in response to a wide range of
cellular stresses, including hypoxia, ischemia, and exposure to
toxic drugs.16,17,21,22 Increased expression of HSP27 serves to
defend a cell against injury or death by acting as chaperones
facilitating proper polypeptide folding and aberrant protein
removal.23–25 Furthermore, HSP27 is a potent antiapoptotic
protein and is a key stabilizer of the actin cytoskeleton; both
of these cellular effects lead to increased resistance against cell
death.26–28 We show in this study that injection of EGFP-
huA1AR lentivirus in A1AR KO mice increased not only the
HSP27 expression, but also colocalization of HSP27 with
F-actin in vivo. Indeed, stress or injury in renal tubule cells
promote association or colocalization of HSP27 with F-actin
leading to cytoprotection in vitro.29,30 Our in vivo study
confirms these previous in vitro findings.
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Figure 10 | Lentivirus-mediated expression of huA1ARs
increases expression of HSP27 in the kidney. (a) Representative
gel images of RT-PCR results from four experiments for GAPDH
and HSP27 from A1AR KO mouse renal cortices. A1AR KO mouse
kidneys were renally injected with EGFP encoding lentivirus or
EGFP-huA1AR encoding lentivirus 48 h before RT-PCR.
Representative results from injected kidneys are shown.
(b) Densitometric quantifications of relative band intensities from
RT-PCR reactions (N¼ 4) for HSP27 mRNA (normalized to GAPDH).
Data in bar graphs are means±s.e.m. #Po0.05 vs EGFP-injected
mice.
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As adenosine exerts renal cortical vasoconstriction
through A1AR activation,
31,32 we tested the hypothesis that
A1AR-mediated renovascular constriction may lead to
hypoxia-mediated upregulation of HIF in A1AR KO mice
in mice expressing huA1ARs. However, we failed to see
induction of HIF protein expression in mice renally injected
with EGFP-huA1AR lentivirus. Therefore, induction of HIF
protein expression does not play a role in EGFP-huA1AR
lentivirus-mediated renal protection.
Gene delivery to treat human diseases has received
significant attention, and several approaches have been
explored to deliver the transgene to the kidney, including
naked DNA, DNA encapsulated in lipid complexes, as well as
viral vectors. Several viral vectors have been used to deliver
the transgene to the kidney, including adenovirus, adeno-
associated virus, retrovirus, and lentivirus. Each of viral
vectors has distinct advantages as well as disadvantages for
use.
Traditionally, adenovirus has been extensively evaluated
for its potential as a gene therapy vector.33,34 Adenovirus
containing transgenes for Cu/Zn-superoxide dismutase,
interleukin-10, interleukin-13, and b2 adrenoreceptors have
been used to protect against renal IR injury, glomerulo-
sclerosis, and sepsis in the kidney.35–38 Adenoviruses have
been widely used for transgene delivery because of its high
tropism, ability to infect nondividing cells, and high titer
yields.33 However, several disadvantages of adenoviral vectors
exist, including the transient nature of the transgene
expression and significant inflammatory responses after
injection. For example, Doerschug et al.39 have reported that
first-generation adenovirus vectors shortened survival in a
murine model of sepsis due to adverse immunological
reactions. Renal IR injury creates a significant inflammatory
response that further contributes to renal injury. Therefore,
potentiation of the inflammatory response with adenoviral
vectors could potentially negate the benefits of cytoprotective
transgene expression.
These disadvantages lead us to use lentivirus to introduce
the transgene in our study to overexpress the A1ARs in vivo.
Lentiviral gene delivery provides several advantages com-
pared with other viral transduction approaches, including a
stable and long-lasting gene transduction and its ability to
infect nondividing post-mitotic cells.40,41 Lentivirus has been
used to express genes in the liver and brain in vivo with great
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Figure 11 | Lentivirus-mediated expression of huA1ARs increases expression of HSP27 and promotes colocalization of F-actin and
HSP27. Representative fluorescent photomicrographs of (a, d, g) phalloidin labeling (green) to visualize (b, e, h) F-actin and HSP27 protein
immunocytochemistry (red) in renal proximal tubules from A1AR KO mouse kidneys. A1AR KO mice kidneys were renally injected with (a–c)
saline, (d–f) EGFP encoding lentivirus (g–i) or EGFP-huA1AR encoding lentivirus 48 h earlier and subjected to 30 min renal ischemia and 24 h
reperfusion. #Indicates proximal tubules with disrupted F-actin staining and * indicates intact F-actin cytoskeleton. Note that increased
HSP27 expression (red) correlated with better preserved F-actin structure (green). Moreover, (c, f, i) HSP27 and F-actin colocalize together
(yellow) showed with 0.25 mm thickness Z-sections. Representative images of four independent experiments.
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efficiency.42 However, application of lentiviral gene delivery
to the kidney has been limited. In the kidney, Gusella et al.41
have shown that intraparenchymal injection of lentivirus
resulted in a robust expression of GFP transgene in the outer
medulla and the corticomedullary junction. In contrast,
vascular injection (renal artery or vein) concentrated
expression in the inner medullary collecting ducts and the
overall renal expression was lower than with intraparench-
ymal injection. As the outer medulla and the corticomedul-
lary junction show the most vulnerability after renal IR, we
chose to inject the lentivirus encoding EGFP-huA1AR into
the renal parenchyma. Similar to the results obtained by
Gusella et al., we also show robust expression of the transgene
(EGFP-huA1AR) in the kidney specifically in the cortex, outer
medulla, and corticomedullary junction.
One of the limitations of the intraparenchymal injection
of virus is that we cannot control the expression of the
protective transgene in a specific cell type (for example,
proximal tubule cells of the S3 segment). However, we show
in this study that intraparenchymal injection of lentivirus
encoding EGFP-huA1AR led to heavy expression in the cortex
and proximal tubules. These are the areas that are the most
susceptible to injury after IR due to the precarious balance
between oxygen supply and demand, high ATP consumption,
and relatively low blood flow.
Another limitation of this study is that we used a warm
(37 1C), global renal IR model to induce ARF in mice.
Although this is a widely used model of renal injury in vivo
and is certainly clinically relevant in the settings of cardiac
arrest, partial nephrectomy and aortovascular procedures
requiring aortic cross-clamping, total kidney ischemia is not
the sole cause of ARF. Sepsis as well as hepatorenal syndrome
(both characterized by severe but subtotal reduction in renal
blood flow) are also frequent causes of clinical ARF.43,44
Furthermore, the pathophysiology and the distribution
pattern of cold IR injury (for example, during cold storage
for cadaveric renal transplantation) markedly differs from
warm IR injury.45,46 Therefore, future studies using other
models of ARF (for example, sepsis or liver failure induced)
would significantly strengthen the potential clinical applica-
tion of lentivirus-mediated A1AR induction in the prevention
of ARF or acute kidney injury.
In summary, we show in this study that selective
expression of human A1AR mRNA and protein is possible
in the mouse kidney and that the expression of this transgene
protects mice lacking A1ARs subjected to renal IR injury.
These findings may have important clinical implications, as
they imply that kidney-specific expression of A1ARs through
lentiviral delivery is a viable therapeutic option in attenuating
the effects of renal IR.
Materials and methods
Mice
Breeder pairs of A1AR heterozygous mice were donated by Dr
J. Schnermann (National Institutes of Health). The genera-
tion and initial characterization of the A1AR KO mice with a
129Sv/J and C57BL/6 background have been described
previously.10,47 The A1AR heterozygous mice were crossed
in our laboratory with C57BL/6 mice (Harlan, Indianapolis,
IN, USA) for 12 generations to create a congenic line of A1AR
KO mice.
Intrarenal lentivirus delivery
Lentivirus encoding EGFP or EGFP-huA1AR was generated
by subcloning EGFP or EGFP-huA1AR (producing a
EGFP–A1AR fusion protein, kindly provided by Dr Raymond
B. Penn, Wake Forest University School of Medicine, NC,
USA) into a shuttle vector (pLL3.7) and cotransfecting
HEK293-FT cells with pLL3.7 expressing EGFP or EGFP-
huA1AR, pVSVG (Invitrogen, Carlsbad, CA, USA) and pD8.9
(from Dr Van Parjs, MIT, Cambridge, MA, USA) using opti-
MEM and Lipofectamine 2000 as described previously.13,48 In
vivo virus transduction to express A1ARs in A1AR KO mice
was performed as described by Nakamura et al.36 with slight
modifications. In anesthetized mice, after temporary occlu-
sion of left renal pedicle, a 31G needle was inserted at the
lower pole of the left kidney parallel to the long axis and was
carefully pushed toward the upper pole. As the needle was
slowly removed, 100 ml filter-purified lentivirus cocktail
(EGFP or EGFP-huA1AR, B5 104 IU/ml) or saline was
injected. Mice were subjected to renal IR 48 h after saline or
virus injection as described below. Preliminary studies
showed that lentiviral-mediated EGFP or EGFP-huA1AR
protein as well as mRNA expression in kidney parenchyma
were robust after 48 h.
Determination of transgene expression with intrarenal
lentivirus injection
We used two techniques to detect the expression of EGFP or
EGFP-huA1AR after intrarenal injection of lentivirus. Forty-
eight hours after the injection, kidneys were removed,
embedded in Tissue-Tek oxytetracycline compound (Fisher
Scientific, Suwanee, GA, USA) and cut into 5 mm sections.
EGFP expression was directly visualized with a fluorescence
microscope (Olympus IX81, Tokyo, Japan), and the images
were captured and stored using SlideBook 4.2 software
(Intelligent Imaging Innovations Inc., Denver, CO, USA) on a
personal computer. In addition, total RNA was extracted
from renal cortices and we performed reverse transcription-
PCR assays for human A1AR and mouse GAPDH as
described previously13,49,50 (Table 1).
Renal IR injury
All renal IR injury procedures were performed 48 h after
intrarenal injection of saline, EGFP, or EGFP-huA1AR. After
Columbia University IACUC approval, adult (25–30 g) male
A1AR KO mice were anesthetized with an intraperitoneal
injection of pentobarbital (50 mg/kg or to effect), and placed
supine on a heating pad under a warming light to maintain
body temperature at 37 1C. Additional pentobarbital was
given as needed on the basis of the mouse’s response to a tail
pinch. Bilateral flank incisions were made, and following
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right nephrectomy, a microaneurysm clip occluded the left
renal pedicle (artery and vein) for 30 min. Thirty minutes of
ischemia was chosen, as previous studies have shown that this
length of ischemic injury minimizes mortality, whereas
maximizing reproducible IR injury in mice.9,10 After
30 min, the microaneurysm clip was removed, 0.5 ml of
saline was given intraperitoneally, the wounds closed in two
layers, and animals allowed to awaken from anesthesia. The
sham mice were subjected to anesthesia and right nephrect-
omy only.
Assessment of renal function after IR injury
Renal function was assessed by measurement of plasma
creatinine 24 h after renal ischemia by a colorimetric method
based on the Jaffe reaction.51
Histological examinations to detect necrosis
Histological examinations to detect necrosis were performed
as described previously.9,10 Morphological assessment was
performed by an experienced renal pathologist (VDD), who
was unaware of the treatment each animal had received. An
established grading scale (renal injury scores of 0–4) for
assessment of necrotic injury to the proximal tubules was
used for the histopathological assessment of IR-induced
damage, as outlined by Jablonski et al.14
Detection of renal tubular apoptosis after IR
We used three independent techniques to detect renal
apoptosis after IR injury: (1) TUNEL staining, (2) micro-
scopic examination of H&E-stained kidney sections, and (3)
immunoblotting for PARP and caspase 3.
Assessment of renal apoptosis TUNEL staining
We used TUNEL staining to detect DNA fragmentation in
apoptosis 24 h after renal injury. In situ labeling of
fragmented DNA was performed with TUNEL staining
(green fluorescence) with a commercially available in situ
cell death detection kit (Roche, Indianapolis, IN, USA),
according to the instructions provided by the manufacturer.
Histological examinations to detect apoptosis
Renal tubular apoptosis was assessed by counting the number
of apoptotic bodies in proximal tubules in the outer stripe of
the corticomedullary junction (expressed as the mean
number of apoptotic bodies per tubule) on H&E-stained
kidney sections. This area is the most severely injured area
after renal IR injury. Apoptosis was identified visually in
H&E-stained kidney sections (original magnification  400)
as nuclear condensation and fragmentation with an intact
plasma membrane. An average of 25–30 tubules per
high-power field was counted and six fields were examined
per slide. The morphological features used to identify
apoptosis include cellular shrinkage and rounding,
cytoplasmic eosinophilia, and chromatin condensation and
fragmentation.
Immunoblot analyses for PARP, caspase 3, HIF-1a, and HIF-2a
We also used immunoblotting of PARP and caspase 3
fragmentations to detect renal cell apoptosis as described
previously.13,52 In brief, renal cortices were dissected on ice,
placed in ice-cold radioimmunoprecipitation buffer (150 mM
NaCl, 50 mM Tris-HCl, 1 mM EDTA, 1% Triton-X, pH 7.4)
and homogenized for 10 s. The samples were then centrifuged
for 10 min at 1000 g and the resulting supernatant was
collected, quantified (for protein concentration), and mixed
to a 1 final concentration with Laemmli’s loading buffer
(50 mM Tris-HCl, 1% 2-mercaptoethanol, 2% sodium
dodecyl sulfate, 0.1% bromo-phenol blue, 10% glycerol).
Equal amounts of protein (30 mg) were subjected to
electrophoresis through a polyacrylamide gel and transferred
Table 1 | Primers used to amplify mRNAs encoding human A1AR, mouse GAPDH, and proinflammatory cytokines based on
published GenBank sequences for mice
Primer
Accession
number Sequence (sense, antisense)
Product
size (bp)
Cycle
number
Annealing
temperature (1C)
Human A1AR NM_000674 5
0-CATTGGGCCACAGACCTACT-30
50-GAAGTAGACCATGTACTCCA-30
190 40 63
Mouse KC J04596 50-CAATGAGCTGCGCTGTCAGTG-30
50-CTTGGGGACACCTTTTAGCATC-30
203 23 60
Mouse MIP-2 X53798 50-CCAAGGGTTGACTTCAAGAAC-30
50-AGCGAGGCACATCAGGTACG-30
282 22 60
Mouse ICAM-1 X52264 50-TGTTTCCTGCCTCTGAAGC-30
50-CTTCGTTTGTGATCCTCCG-30
409 21 60
Mouse TNF-a X02611 50-CCTCAGCCTCTTCTCCTTCCT-30
50-GGTGTGGGTGAGGAGCA-30
290 24 65
Mouse MCP-1 NM_011333 50-ACCACAGTCCATGCCATCAC-30
50-CACCACCCTGTTGCTGTAGCC-30
312 22 60
Mouse HSP27 NM_024441 50-CCTAAGGTCTGGCATGGTA-30
50-AGGAAGCTCGTTGTTGAAGC-30
373 26 66
Mouse GAPDH M32599 50-ACCACAGTCCATGCCATCAC-30
50-CACCACCCTGTTGCTGTAGCC-30
450 15 65
A1AR, A1 adenosine receptor; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HSP27, heat shock protein 27; ICAM-1, intercellular adhesion molecule-1; KC, keratinocyte-
derived chemokine; MCP-1, monocyte chemoattractant protein 1; MIP-2, macrophage inflammatory protein 2; TNFa, tumor necrosis factor alpha.
Respective anticipated RT-PCR product size, PCR cycle number for linear amplification and annealing temperatures used for each primer are also provided.
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to polyvinylidene difluoride membranes. Primary mouse
antibodies for PARP, caspase 3, HIF-1a, and HIF-2a were
obtained from Santa Cruz Biotechnologies (Santa Cruz, CA,
USA). The secondary antibody (goat anti-rabbit or anti-
mouse IgG conjugated to horseradish peroxidase at 1:5000
dilution) was detected with enhanced chemiluminescence
immunoblotting detection reagents (Amersham, Piscataway,
NJ, USA), with subsequent exposure to a CCD camera
coupled to a UVP Bio-imaging System (Upland, CA, USA)
and a personal computer. The band intensities of the
immunoblots were within the linear range of exposure for
all experiments.
Assessment of renal inflammation
Renal inflammation after IR injury was determined (1) with
detection of neutrophil infiltration and ICAM-1 expression
with immunohistochemistry 24 h after renal IR and (2) by
measuring mRNA encoding markers of inflammation,
including KC, ICAM-1, MCP-1, MIP-2, and TNF-a.
Immunohistochemistry for neutrophil or ICAM-1
Immunohistochemistry for neutrophil or ICAM-1 was
performed as described previously9,10 with a monoclonal
antibody against PMN (clone 7/4) or ICAM-1 (CD54,
Serotec, Raleigh, NC, USA). A primary antibody that
recognized IgG2a (MCA1212, Serotec, Raleigh, NC, USA)
was used as a negative isotype control in all experiments.
Intrarenal neutrophil infiltration was also quantified by
manual counting of polymorphonuclear cells in H&E slides
by a renal pathologist (V.D.D.).
Semiquantitative reverse transcription-PCR assay for
proinflammatory mRNAs and HSP27
Semiquantitative reverse transcription-PCR assay for proin-
flammatory mRNAs and HSP27 was performed as described
previously13,49,50 (Table 1).
Filamentous actin (F-actin) staining after renal IR injury. As
breakdown of F-actin occurs early after renal IR, we
visualized the F-actin cytoskeleton by staining with phalloi-
din as an early index of renal injury.53,54 Twenty-four hours
after renal IR, kidneys were embedded in Tissue-Tek
oxytetracycline compound (Fisher Scientific, Pittsburgh, PA,
USA) and cut into 5 mm sections. To reduce background
staining, the sections were incubated in 1% fetal bovine
serum dissolved in phosphate-buffered saline (PBS) for
10 min at room temperature. The sections were then stained
with Alexafluor 594 (Red)-labeled phalloidin (Invitrogen) for
30 min at 37 1C in a humidified chamber in the dark. Sections
were then washed twice in PBS and mounted with
Vectashield (Vector Laboratories, Burlingame, CA, USA).
Overlap (coexpression) of F-actin (red) with EGFP-A1AR
expression (green) was examined with an Olympus IX81
epifluorescence microscope and analyzed with the Slidebook
software (Intelligent Imaging Innovations Inc., Denver, CO,
USA).
Immunohistochemistry for HSP27 and huA1AR. Twenty-four
hours after renal IR, kidneys were embedded in Tissue-Tek
oxytetracycline compound and cut into 5mm sections. The
sections were air-dried and fixed in 4% paraformaldehyde in
PBS and briefly washed in PBS. To reduce background
staining, the sections were incubated in 1% fetal bovine
serum dissolved in PBS for 10 min at room temperature. The
sections were then stained with Alexafluor 488 (Green)-
labeled phalloidin (Invitrogen) for 30 min at 37 1C in a
humidified chamber in the dark. Excess phalloidin was
removed by washing twice in PBS and the sections were
incubated with anti-HSP27 antibody (Abcam, Cambridge,
MA, USA) antibody for 1 h at room temperature. After
washing with PBS, the sections were incubated with a goat
anti-rabbit Alexa Fluor 594 conjugated secondary antibody
(red) for 1 h at room temperature in the dark and mounted
with Vectashield (Vector Laboratories). Alexafluor 488-
labeled phalloidin stain provided significantly intense
staining (B100-fold higher) and preliminary experiments
showed that the contribution of EGFP fluorescence at the
settings to visualize green F-actin stain was minimal (data not
shown). Colocalization (yellow) of F-actin (green) with
HSP27 (red) was determined with Z sections taken
with a step size of 0.25 mm (for total of Z-distance of 5 mm)
with an Olympus Spinning Disk Confocal System microscope
and analyzed with the Slidebook software using Peason’s
correlation.
To detect the huA1AR expression after EGFP-huA1AR
lentivirus injection, we performed the huA1AR immunohis-
tochemistry. Oxytetracycline-embedded kidney sections were
incubated with anti-huA1AR antibody (Affinity BioReagents,
Golden, CO, USA) antibody for 1 h at room temperature.
After washing with PBS, the sections were incubated with a
goat anti-rabbit Alexa Fluor 594 conjugated secondary
antibody (red) for 1 h at room temperature in the dark and
mounted with Vectashield (Vector Laboratories). Colocaliza-
tion (yellow) of EGFP (green) with huA1AR (red) was
determined as described above.
Statistical analysis
The data were analyzed with t-test when means between two
groups were compared or with one-way (for example, plasma
creatinine) ANOVA plus Tukey post hoc multiple comparison
test to compare mean values across multiple treatment
groups. The ordinal values of the Jablonski scale were
analyzed by the Kruskal–Wallis nonparametric test with
Dunn post-test comparison among groups. In all cases,
Po0.05 was taken to indicate significance. All data are
expressed as mean±s.e.m.
Reagents
Unless otherwise specified, all chemicals were obtained from
Sigma (St Louis, MO, USA).
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